News, Company Announcements, Industry Insights, Project Updates, Business Expansion, Research Achievements, Corporate Culture, Media Coverage, Employee Stories, Innovation Highlights

long8-龙8(国际)头号玩家唯一官方网站

Home/Newsroom

A Customer-centric, Innovative
and Reliable CDMO with Global Solutions

News

Case Studies & Whitepapers
Events
News
Marketing Collateral

Newsletters

1-22 of 194 result

News Aug 11, 2022

Porton Pharma Solutions Ltd. to Expand Operations in Europe

News Aug 11, 2022

Porton Pharma Solutions Ltd. to Expand Operations in Europe

News Mar 11, 2022

Porton Announced to Acquire China Gateway Pharmaceutical Development Co., Ltd.

News Mar 11, 2022

Porton Announced to Acquire China Gateway Pharmaceutical Development Co., Ltd.

News Mar 02, 2022

Porton Plans to Invest 420 million to Expand CDMO Production Capacity of Small Molecule API

News Mar 02, 2022

Porton Plans to Invest 420 million to Expand CDMO Production Capacity of Small Molecule API

News Feb 10, 2022

Porton Invests to Expand API CDMO Capacity

News Feb 10, 2022

Porton Invests to Expand API CDMO Capacity

News Jan 20, 2022

Porton expects strongly growth in revenue and net profit in 2021

...

8 9 10

...

long8-龙8(国际)头号玩家唯一官方网站

Small Molecules CDMO Services

Tides CDMO Services

Biologics and Conjugates CDMO Services

Advanced Therapy Medicinal
Products CRO & CDMO Services

Crystallization

Bio Catalysis

Metal Catalysis

Flow Chemistry

Prep-Chromatography

Milling

Chemical Engineering and Technologies

ESG Concept

ESG Policies

ESG Reports

Case Studies & Whitepapers

Events

News

Marketing Collateral

About Us

Global Presence

Corporate Governance

Investors

Digital Transformation

Career

Become part of Porton' s community to access personalized insights and resources.

About Us

Drug Modalities

Technical Solutions

Become part of Porton' s community to access personalized insights and resources.